Detalhe da pesquisa
1.
Myeloid differentiation factor-2 activates monocytes in patients with dilated cardiomyopathy.
Immunology
; 167(1): 40-53, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35502635
2.
Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors.
Cancer Immunol Immunother
; 70(12): 3405-3419, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33870463
3.
Transcriptional regulation of urate transportosome member SLC2A9 by nuclear receptor HNF4α.
Am J Physiol Renal Physiol
; 307(9): F1041-51, 2014 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25209865
4.
High-Mobility Group Box Protein 1 Is an Independent Prognostic Marker for All-Cause Mortality in Patients With Dilated Cardiomyopathy.
Am J Cardiol
; 178: 119-123, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35787339
5.
MD-2 is a new predictive biomarker in dilated cardiomyopathy and exerts direct effects in isolated cardiomyocytes.
Int J Cardiol
; 270: 278-286, 2018 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30082120